These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7421893)

  • 61. Oral contraceptives. The good news.
    Hulka BS
    JAMA; 1983 Mar; 249(12):1624-5. PubMed ID: 6827743
    [No Abstract]   [Full Text] [Related]  

  • 62. [Mass population screening for endometrial cancer].
    Yajima S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Sep; 36(9):1401-2. PubMed ID: 6491416
    [No Abstract]   [Full Text] [Related]  

  • 63. The epidemiology of endometrial cancer.
    Parazzini F; La Vecchia C; Bocciolone L; Franceschi S
    Gynecol Oncol; 1991 Apr; 41(1):1-16. PubMed ID: 2026352
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endometrial histology with oral contraceptives.
    Baveja R; Palni R; Mukherjee M
    J Obstet Gynaecol India; 1977 Apr; 27(2):195-7. PubMed ID: 923994
    [No Abstract]   [Full Text] [Related]  

  • 65. Inadvertent pregnancies in oral contraceptive users.
    Med J Aust; 1989 Aug; 151(3):178, 180. PubMed ID: 2755382
    [No Abstract]   [Full Text] [Related]  

  • 66. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
    Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
    [No Abstract]   [Full Text] [Related]  

  • 67. Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer.
    Carlson MJ; Thiel KW; Yang S; Leslie KK
    Discov Med; 2012 Sep; 14(76):215-22. PubMed ID: 23021376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Understanding obesity and endometrial cancer risk: opportunities for prevention.
    Schmandt RE; Iglesias DA; Co NN; Lu KH
    Am J Obstet Gynecol; 2011 Dec; 205(6):518-25. PubMed ID: 21802066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case-control study of oral contraceptive use and incident breast cancer.
    Rosenberg L; Zhang Y; Coogan PF; Strom BL; Palmer JR
    Am J Epidemiol; 2009 Feb; 169(4):473-9. PubMed ID: 19074777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.
    Epplein M; Reed SD; Voigt LF; Newton KM; Holt VL; Weiss NS
    Ann Epidemiol; 2009 Jan; 19(1):1-7. PubMed ID: 19064186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hormones and breast and endometrial cancers: preventive strategies and future research.
    Hulka BS; Brinton LA
    Environ Health Perspect; 1995 Nov; 103 Suppl 8(Suppl 8):185-9. PubMed ID: 8741781
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism.
    Catherino WH; Jeng MH; Jordan VC
    Br J Cancer; 1993 May; 67(5):945-52. PubMed ID: 8494728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA).
    Voigt LF; Deng Q; Weiss NS
    Cancer Causes Control; 1994 May; 5(3):227-33. PubMed ID: 8061170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex hormones and gynaecological cancer.
    Scott JS
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1657-8. PubMed ID: 6805643
    [No Abstract]   [Full Text] [Related]  

  • 76. Exogenous hormones in the aetiology of cancer in women.
    Vessey MP
    J R Soc Med; 1984 Jul; 77(7):542-9. PubMed ID: 6379176
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.
    La Vecchia C; Decarli A; Fasoli M; Franceschi S; Gentile A; Negri E; Parazzini F; Tognoni G
    Br J Cancer; 1986 Aug; 54(2):311-7. PubMed ID: 3741766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2.
    Law ML; Kao FT; Wei Q; Hartz JA; Greene GL; Zarucki-Schulz T; Conneely OM; Jones C; Puck TT; O'Malley BW
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2877-81. PubMed ID: 3472240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk factors of female cancers in Ragusa population (Sicily)--1. Endometrium and cervix uteri cancers.
    Cusimano R; Dardanoni G; Dardanoni L; La Rosa M; Pavone G; Tumino R; Gafà L
    Eur J Epidemiol; 1989 Sep; 5(3):363-71. PubMed ID: 2792311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recent time trends in uterine cancer.
    Persky V; Davis F; Barrett R; Ruby E; Sailer C; Levy P
    Am J Public Health; 1990 Aug; 80(8):935-9. PubMed ID: 2368853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.